<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38932451</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>A 3-month-old neonatal rhesus macaque HFMD model caused by coxsackievirus B1 infection and viral tissue tropism.</ArticleTitle><Pagination><StartPage>e29707</StartPage><MedlinePgn>e29707</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29707</ELocationID><Abstract><AbstractText>Coxsackievirus B1 (CVB1), an enterovirus with multiple clinical presentations, has been associated with potential long-term consequences, including hand, foot, and mouth disease (HFMD), in some patients. However, the related animal models, transmission dynamics, and long-term tissue tropism of CVB1 have not been systematically characterized. In this study, we established a model of CVB1 respiratory infection in rhesus macaques and evaluated the clinical symptoms, viral load, and immune levels during the acute phase (0-14 days) and long-term recovery phase (15-30 days). We also investigated the distribution, viral clearance, and pathology during the long-term recovery period using 35 postmortem rhesus macaque tissue samples collected at 30 days postinfection (d.p.i.). The results showed that the infected rhesus macaques were susceptible to CVB1 and exhibited HFMD symptoms, viral clearance, altered cytokine levels, and the presence of neutralizing antibodies. Autopsy revealed positive viral loads in the heart, spleen, pancreas, soft palate, and olfactory bulb tissues. HE staining demonstrated pathological damage to the liver, spleen, lung, soft palate, and tracheal epithelium. At 30 d.p.i., viral antigens were detected in visceral, immune, respiratory, and muscle tissues but not in intestinal or neural tissues. Brain tissue examination revealed viral meningitis-like changes, and CVB1 antigen expression was detected in occipital, pontine, cerebellar, and spinal cord tissues at 30 d.p.i. This study provides the first insights into CVB1 pathogenesis in a nonhuman primate model of HFMD and confirms that CVB1 exhibits tissue tropism following long-term infection.</AbstractText><CopyrightInformation>© 2024 The Author(s). Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suqin</LastName><ForeName>Duan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4425-3141</Identifier><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yongjie</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Zhang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ming</LastName><ForeName>Zhang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanyan</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weihua</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quan</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mingxue</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenting</LastName><ForeName>Sun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lixiong</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hongjie</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jie</LastName><ForeName>Tang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jingshan</LastName><ForeName>Hou</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zijun</LastName><ForeName>Deng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fengmei</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaohui</LastName><ForeName>Ma</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhanlong</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Disease, Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Yunnan province applied basic research special project-general project</Agency><Country /></Grant><Grant><Agency>CAMS Innovation Fund for Medical Sciences</Agency><Country /></Grant><Grant><Agency>National Resource Center for Nonhuman Primates, Major Science and Technology Special Projects in Yunnan Province, Kunming Science and Technology Innovation and Service Capacity Enhancement Program Key Projects</Agency><Country /></Grant><Grant><Agency>Peking Union Medical College-Central University Basic Scientific Research Business Fee</Agency><Country /></Grant><Grant><Agency>National Key R&amp;D Project of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008253" MajorTopicYN="Y">Macaca mulatta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056189" MajorTopicYN="Y">Viral Tropism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="Y">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus B1</Keyword><Keyword MajorTopicYN="N">foot and mouth disease</Keyword><Keyword MajorTopicYN="N">hand</Keyword><Keyword MajorTopicYN="N">long‐term tissue damage</Keyword><Keyword MajorTopicYN="N">rhesus macaques</Keyword><Keyword MajorTopicYN="N">tissue tropism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38932451</ArticleId><ArticleId IdType="doi">10.1002/jmv.29707</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Tsang JOL, Zhou J, Zhao X, et al. Development of three‐dimensional human intestinal organoids as a physiologically relevant model for characterizing the viral replication kinetics and antiviral susceptibility of enteroviruses. Biomedicines. 2021;9:88.</Citation></Reference><Reference><Citation>Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018;37:391‐398.</Citation></Reference><Reference><Citation>Fischer TK, Simmonds P, Harvala H. The importance of enterovirus surveillance in a post‐polio world. Lancet Infect Dis. 2022;22:e35‐e40.</Citation></Reference><Reference><Citation>Chen BS, Lee HC, Lee KM, Gong YN, Shih SR. Enterovirus and encephalitis. Front Microbiol. 2020;11:261.</Citation></Reference><Reference><Citation>Annoni G, De Rienzo F, Nonini S, et al. Enterovirus fulminant myocarditis as cause of acute heart failure in a newborn. IJC Heart &amp; Vasculature. 2022;42:101093.</Citation></Reference><Reference><Citation>Puenpa J, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. The history of enterovirus A71 outbreaks and molecular epidemiology in the Asia‐Pacific region. J Biomed Sci. 2019;26:75.</Citation></Reference><Reference><Citation>Wong SSY, Yip CCY, Lau SKP, Yuen KY. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect. 2010;138:1071‐1089.</Citation></Reference><Reference><Citation>Hosoya M, Kawasaki Y, Sato M, et al. Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003. J Clin Microbiol. 2007;45:112‐120.</Citation></Reference><Reference><Citation>Zhao TS, Du J, Sun DP, et al. A review and meta‐analysis of the epidemiology and clinical presentation of coxsackievirus A6 causing hand‐foot‐mouth disease in China and global implications. Rev Med Virol. 2020;30:e2087.</Citation></Reference><Reference><Citation>Chu PY, Tyan YC, Chen YS, et al. Transmission and demographic dynamics of coxsackievirus B1. PLoS One. 2015;10:e0129272.</Citation></Reference><Reference><Citation>Yin Z, Wu Y, Zhu R, et al. Development of A neonatal mouse model for coxsackievirus B1 antiviral evaluation. Virologica Sinica. 2021;36:1575‐1584.</Citation></Reference><Reference><Citation>Kissova R, Pastuchova K, Lengyelova V, et al. Surveillance program of clinical samples for polio and non‐polio enteroviruses in the Slovak Republic during the 1958‐2020 period. Viruses. 2022;14:1957.</Citation></Reference><Reference><Citation>Schleicher EM. An improved hematoxylin‐eosin stain for sections of marrow units. Stain Technol. 1953;28:119‐123.</Citation></Reference><Reference><Citation>Liu H, Zhu R, Liu C, et al. Evaluation of decalcification techniques for rat femurs using HE and immunohistochemical staining. BioMed Res Int. 2017;2017:9050754.</Citation></Reference><Reference><Citation>Chuang YY, Huang YC. Enteroviral infection in neonates. J Microbiol Immunol Infect. 2019;52:851‐857.</Citation></Reference><Reference><Citation>Fan YK, Liu YP. Magnetic resonance imaging features of pediatric coxsackievirus encephalitis. J Belg Soc Radiol. 2019;103:6.</Citation></Reference><Reference><Citation>Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 2013;64:74‐78.</Citation></Reference><Reference><Citation>He YL, Zhang X, Zha J, Dai WJ, Luo F, Shen T. Analysis on detection of enterovirus nucleotides in feces samples of hand‐foot‐mouth disease patients after recovery. Zhonghua yu fang yi xue za zhi. 2011;45:1073‐1076.</Citation></Reference><Reference><Citation>Han J, Wang Y, Gan X, Song J, Sun P, Dong XP. Serum cytokine profiles of children with human enterovirus 71‐associated hand, foot, and mouth disease. J Med Virol. 2014;86:1377‐1385.</Citation></Reference><Reference><Citation>Zhang W, Huang Z, Huang M, Zeng J. Predicting severe enterovirus 71‐infected hand, foot, and mouth disease: cytokines and chemokines. Mediators Inflamm. 2020;2020:9273241.</Citation></Reference><Reference><Citation>He Y, Feng Z, Wang W, et al. Global cytokine/chemokine profile identifies potential progression prediction indicators in hand‐foot‐and‐mouth disease patients with enterovirus A71 infections. Cytokine. 2019;123:154765.</Citation></Reference><Reference><Citation>Compagnoli Carmona RC, Caetano Machado B, Aparecida de Sousa C, et al. Distribution of species enterovirus B in patients with central nervous system infections in São Paulo state, Brazil. J Med Virol. 2020;92:3849‐3856.</Citation></Reference><Reference><Citation>Cameron Smail R, O'Neill JH, Andresen D. Brainstem encephalitis caused by Coxsackie A16 virus in a rituximab‐immunosuppressed patient. BMJ Case Rep. 2019;12:e230177.</Citation></Reference><Reference><Citation>Brecht M, Jyoti R, McGuire W, Chauhan M. Letters to the editor. J Paediatr Child Health. 2010;46:699‐701.</Citation></Reference><Reference><Citation>Dalldorf G, Sickles GM. An unidentified, filtrable agent isolated from the feces of children with paralysis. Science. 1948;108:61‐62.</Citation></Reference><Reference><Citation>Abdelkhalek I, Seghier M, Yahia AB, et al. Molecular epidemiology of coxsackievirus type B1. Arch Virol. 2015;160:2815‐2821.</Citation></Reference><Reference><Citation>Fann Y, Li F, Wu W, Hong C, Shiu W, Wu K. Sepsis‐like illness caused by enterovirus in neonate. Acta Paediatr Sin. 1994;35:161‐179.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Increased detections and severe neonatal disease associated with coxsackievirus B1 infection—United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:553‐556.</Citation></Reference><Reference><Citation>Lee S, Yang JH, Lee J, Kim YO. Serotype analysis of pediatric enteroviral meningitis in Gwangju, Republic of Korea: number of annual cases, distribution by age group, and characteristics of each serotype. J Clin Virol. 2022;153:105192.</Citation></Reference><Reference><Citation>Ji H, Fan H, Lu P, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. BMC Infect Dis. 2019;19:79.</Citation></Reference><Reference><Citation>Tao Z, Wang H, Li Y, et al. Molecular epidemiology of human enterovirus associated with aseptic meningitis in Shandong province, China, 2006–2012. PLoS One. 2014;9:e89766.</Citation></Reference><Reference><Citation>Chen W, Weng YW, Zhang YJ, et al. Molecular epidemiology of coxsackievirus B1‐5 associated with HFMD in Fujian province, China, 2011–2016. Biomed Environ Sci. 2019;32:633‐638.</Citation></Reference><Reference><Citation>Costa MM, Lisboa M, Romeu JC, Caldeira J, De Queiroz V. Henoch‐schonlein purpura associated with coxsackie‐virus B1 infection. Clin Rheumatol. 1995;14:488‐490.</Citation></Reference><Reference><Citation>Chou LL, Chang CP, Wu LC. Neonatal coxsackievirus B1 infection associated with severe hepatitis: report of three cases. Zhonghua Minguo xiao er ke yi xue hui za zhi. 1995;36:296‐299.</Citation></Reference><Reference><Citation>Pauwels S, Moor BD, Stas K, et al. Coxsackievirus B1 peritonitis in a patient treated with continuous ambulatory peritoneal dialysis: a case report and brief review of the literature. Clin Microbiol Infect. 2012;18:E431‐E434.</Citation></Reference><Reference><Citation>Nekoua MP, Mercier A, Alhazmi A, Sane F, Alidjinou EK, Hober D. Fighting enteroviral infections to prevent type 1 diabetes. Microorganisms. 2022;10:768.</Citation></Reference><Reference><Citation>Hoorn B, Tyrrell DA. On the growth of certain “newer” respiratory viruses in organ cultures. Br J Exp Pathol. 1965;46:109‐118.</Citation></Reference><Reference><Citation>Wang J, Zhang Y, Zhang X, et al. Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques. Virology. 2017;500:198‐208.</Citation></Reference><Reference><Citation>Kim KS, Hufnagel G, Chapman NM, Tracy S. The group B coxsackieviruses and myocarditis. Rev Med Virol. 2001;11:355‐368.</Citation></Reference><Reference><Citation>Lloyd RE, Tamhankar M, Lernmark Å. Enteroviruses and type 1 diabetes: multiple mechanisms and factors? Annu Rev Med. 2022;73:483‐499.</Citation></Reference><Reference><Citation>Bruce Sundstrom J, A. Ansari A. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts. Transpl Immunol. 1995;3:273‐289.</Citation></Reference><Reference><Citation>Chang LY, Lin HY, Gau SSF, et al. Enterovirus A71 neurologic complications and long‐term sequelae. J Biomed Sci. 2019;26:57.</Citation></Reference><Reference><Citation>Kennedy PGE. An overview of viral infections of the nervous system in the immunosuppressed. J Neurol. 2021;268:3026‐3030.</Citation></Reference><Reference><Citation>Leite J, Ribeiro A, Gonçalves D, Sargento‐Freitas J, Trindade L, Duque V. Cerebral venous thrombosis as rare presentation of herpes simplex virus encephalitis. Case Rep Infect Dis. 2019;2019:7835420.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>